IFNA1 and COVID-19: He concluded that IFNλs are necessary for preventing overactivation of the innate immune response during infection.73 In human studies, Dr Andreakos and his team studied IFNλs in COVID-19 and flu patients and demonstrated that COVID-19 patients exhibit impaired and delayed type I and type III IFN production.